These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17094381)

  • 1. Chemosensitivity testing of paclitaxel versus docetaxel in human gynecological carcinomas: a comparison with carboplatin.
    Koshiyama M; Kinezaki M; Uchida T; Sumitomo M
    Anticancer Res; 2006; 26(5B):3655-9. PubMed ID: 17094381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in human gynecological carcinomas: a comparison with cisplatin.
    Koshiyama M; Kinezaki M; Uchida T; Sumitomo M
    Anticancer Res; 2005; 25(6C):4499-502. PubMed ID: 16334133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.
    Vasey PA; Jayson GC; Gordon A; Gabra H; Coleman R; Atkinson R; Parkin D; Paul J; Hay A; Kaye SB;
    J Natl Cancer Inst; 2004 Nov; 96(22):1682-91. PubMed ID: 15547181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboplatin-paclitaxel- and carboplatin-docetaxel-induced cytotoxic effect in epithelial ovarian carcinoma in vitro.
    Engblom P; Rantanen V; Kulmala J; Grènman S
    Cancer; 1999 Nov; 86(10):2066-73. PubMed ID: 10570433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel and carboplatin as first-line chemotherapy in patients with advanced gynecological tumors. A phase I/II trial of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study Group.
    Pfisterer J; du Bois A; Wagner U; Quaas J; Blohmer JU; Wallwiener D; Hilpert F;
    Gynecol Oncol; 2004 Mar; 92(3):949-56. PubMed ID: 14984965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paclitaxel and carboplatin with or without pirarubicin (THP-ADR) as first line chemotherapy in elderly patients].
    Nagao S; Okimoto N; Hongo A; Mizutani Y; Kodama J; Yoshinouchi M; Hiramatsu Y; Kudo T
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):243-9. PubMed ID: 12610873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancer.
    Kawahara M; Atagi S; Komuta K; Yoshioka H; Kawasaki M; Fujita Y; Yonei T; Ogushi F; Kubota K; Nogami N; Tsuchiya M; Shibata K; Tomizawa Y; Minato K; Fukuoka K; Asami K; Yamanaka T;
    Anticancer Res; 2013 Oct; 33(10):4631-7. PubMed ID: 24123041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemosensitivity testing of irinotecan (CPT-11) in ovarian and endometrial carcinomas: a comparison with cisplatin.
    Koshiyama M; Fujii H; Kinezaki M; Ohgi S; Konishi M; Hidetaka N; Hayashi M; Yoshida M
    Anticancer Res; 2000; 20(3A):1353-8. PubMed ID: 10928043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines.
    Smith JA; Ngo H; Martin MC; Wolf JK
    Gynecol Oncol; 2005 Jul; 98(1):141-5. PubMed ID: 15963813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental leucine aminopeptidase (P-LAP) expression is associated with chemosensitivity in human endometrial carcinoma.
    Shibata K; Kikkawa F; Kondo C; Mizokami Y; Kajiyama H; Ino K; Nomura S; Mizutani S
    Gynecol Oncol; 2004 Nov; 95(2):307-13. PubMed ID: 15491750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of docetaxel in the treatment of newly diagnosed advanced ovarian cancer.
    Vasey PA
    J Clin Oncol; 2003 May; 21(10 Suppl):136s-144s. PubMed ID: 12743129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.
    Koshiyama M; Fujii H; Kinezaki M; Morita Y; Nanno H; Yoshida M
    Anticancer Res; 2001; 21(4B):2925-32. PubMed ID: 11712788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of radiation effects by combined docetaxel and carboplatin treatment in vitro.
    Amorino GP; Hamilton VM; Choy H
    Radiat Oncol Investig; 1999; 7(6):343-52. PubMed ID: 10644057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer.
    Havrilesky LJ; Pokrzywinski R; Revicki D; Higgins RV; Nycum LR; Kohler MF; Berchuck A; Myers ER; Secord AA
    Cancer; 2012 Jan; 118(2):386-91. PubMed ID: 21598242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group.
    Vergote I; Debruyne P; Kridelka F; Berteloot P; Amant F; Honhon B; Lybaert W; Leunen K; Geldhof K; Verhoeven D; Forget F; Vuylsteke P; D'Hondt L; Huizing M; Van den Bulck H; Laenen A
    Gynecol Oncol; 2015 Aug; 138(2):278-84. PubMed ID: 26049123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro responses of ovarian cancers to platinums and taxanes.
    Kornblith P; Wells A; Gabrin MJ; Piwowar J; Chattopadhyay A; George LD; Ochs RL; Burholt D
    Anticancer Res; 2003; 23(1B):543-8. PubMed ID: 12680143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin plus paclitaxel in the treatment of gynecologic malignancies: the Cleveland Clinic experience.
    Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-26-S15-29. PubMed ID: 9346218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer.
    Havrilesky LJ; Garfield CF; Barnett JC; Cohn DE
    Gynecol Oncol; 2012 Jun; 125(3):631-4. PubMed ID: 22446408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The platelet-sparing effect of carboplatin and docetaxel combination chemotherapy for lung cancer].
    Ryo H; Isobe K; Toyama K; Sugino K; Sano G; Yamada H; Hiroi M; Kimura K
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1435-9. PubMed ID: 14584274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapy.
    Markman J; Zanotti K; Webster K; Belinson J; Peterson G; Kulp B; Markman M
    Gynecol Oncol; 2004 Feb; 92(2):592-5. PubMed ID: 14766252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.